Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

CNS Drugs

Issue Special Issue 1/2009

Content (8 Articles)

CME Overview

Advances in Attention-Deficit Hyperactivity Disorder Treatment

Introduction

Toward a New Understanding of Attention-Deficit Hyperactivity Disorder

Thomas J. Spencer

Review Article

Issues in the Management of Patients with Complex Attention-Deficit Hyperactivity Disorder Symptoms

Thomas J. Spencer

Review Article

Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults

Sharon B. Wigal

Review Article

Toward a New Understanding of Attention-Deficit Hyperactivity Disorder Pathophysiology

Amy F. T. Arnsten

Review Article

Alpha-2 Adrenergic Agonists in Children with Inattention, Hyperactivity and Impulsiveness

Lawrence Scahill

CME Post-test

Post-Test Questions

Evaluation Form

Advances in ADHD Treatment: A Focus on the Role of Noradrenergic and Alpha-2a Receptor Modulation

Oct 09
Issue: 10/2009
Nov 09
Issue: 11/2009

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more